MO5 - CARDIO-ONCOLOGY AND VASCULAR INNOVATION: MECHANISMS AND OUTCOMES - ABSTRACT PRESENTATIONS

Chair(s)

• 

  Ludovic Mouttet, BSc

  PhD Candidate
  McGill University
  McGill University

Presenting Author(s)

• 

  Mehima Kang, MD

  Resident
  UBC
  UBC
• 

  Aman Singh, MSc PhD (he/him/his)

  PhD Candidate
  Western University

  Handouts / Images
• 

  Priya Mistry, MSc (she/her/hers)

  PhD Candidate
  University of Toronto
• 

  Arya Ardehali, BSc (he/him/his)

  Medical Student
  The University Of British Columbia
  The University of British Columbia

Abstracts in this session examine the intersection of cancer and cardiovascular disease. Topics include endothelial dysfunction associated with BRCA2 loss, tumor microenvironment influences on cardiotoxicity, and healthcare utilization in cardiac amyloidosis. Presentations span both basic mechanisms and clinical outcomes in cardio-oncology.

Presentations:

Mehima Kang – Clinical Predictors and Healthcare Utilization Among Cardiac Amyloidosis Patients in British Columbia

Aman Singh – Endothelial Cell-Specific Loss of Breast Cancer Susceptibility Gene 2 Exacerbates Angiotensin II-Induced Endothelial Dysfunction

Priya Mistry – Investigating How the Tumour Microenvironment Predisposes the Cardiovascular System to Cancer-Therapy Induced Cardiotoxicity

Arya Ardehali – Preoperative Baseline Troponin as a Predictor of Major Adverse Cardiac Events Following Kidney Transplantation in Patients with End-Stage Kidney Disease